TheyaVue for Dry Eyes: Does It Actually Help?

TheyaVue may provide meaningful antioxidant and anti-inflammatory support that benefits dry eye sufferers, but it was not formulated specifically for dry eye disease and it does not contain the most evidence-backed dry eye nutrient — omega-3 fatty acids. If dry eyes are your primary complaint, TheyaVue is a reasonable supplement to consider for overall ocular health support, but it should be paired with omega-3s rather than used as a standalone dry eye treatment.

As a Registered Dietitian Nutritionist who has reviewed the evidence on ocular nutrition for years, I want to give you the most honest picture I can: this is a supplement designed for macular health and AMD prevention that happens to contain several ingredients with legitimate relevance to dry eye. Understanding exactly which ones matter, what they do, and what the formula is missing is the purpose of this article.

TL;DR

• TheyaVue contains three ingredients with direct relevance to dry eye: Vitamin C (aqueous humor antioxidant), Quercetin (anti-inflammatory), and NAC (ocular surface glutathione support).
• TheyaVue does NOT contain omega-3 fatty acids (DHA/EPA), which is the most evidence-based nutritional intervention specifically for dry eye disease and Meibomian gland dysfunction.
• For dry eye sufferers, TheyaVue may support overall ocular surface antioxidant and anti-inflammatory status — it just won’t replace the lipid layer support that omega-3s provide.
• The 60-day money-back guarantee makes it low-risk to trial for dry eye sufferers who also want comprehensive eye antioxidant coverage.
• Best approach: TheyaVue + a separate high-quality omega-3 supplement for complete dry eye nutritional support.

Check Current Pricing on the Official TheyaVue Website{rel=“nofollow sponsored”}

---

1. The Direct Answer

Does TheyaVue help with dry eyes? The honest answer is: partially, and indirectly.

TheyaVue’s primary design target is the macula — the central retinal zone responsible for sharp visual acuity and most vulnerable to age-related oxidative damage. Its formula concentrates on fat-soluble carotenoids (Lutein, Zeaxanthin), plant antioxidants (Bilberry, Quercetin, Rutin), and water-soluble antioxidants (Vitamin C, NAC) that protect retinal photoreceptors and the lens from oxidative stress.

Dry eye disease operates through a different primary mechanism: tear film instability caused by either Meibomian gland dysfunction (lipid layer deficiency) or aqueous tear deficiency. The most evidence-backed nutritional lever for this condition is omega-3 fatty acid supplementation, which improves Meibomian gland function and reduces tear film evaporation. TheyaVue contains no omega-3s.

However, oxidative stress and chronic low-grade inflammation are increasingly recognized as contributing factors in dry eye disease — particularly in the evaporative form associated with Meibomian gland dysfunction. This is where TheyaVue’s formula has genuine relevance to dry eye sufferers, even if it was not designed with them in mind. For a comprehensive look at what the evidence shows for nutritional dry eye interventions, Dry Eye Supplements Evidence covers the full research landscape.

---

2. What Causes Dry Eyes? A Brief Mechanism Overview

To understand why some of TheyaVue’s ingredients are relevant to dry eye and others are not, it helps to understand the basic physiology of the tear film and how it breaks down.

The tear film is a three-layered structure sitting on the ocular surface:

1. The lipid layer (outermost) — secreted by Meibomian glands in the eyelid margins; prevents evaporation of the aqueous layer beneath it
2. The aqueous layer (middle) — produced by the lacrimal glands; contains water, electrolytes, proteins, and growth factors
3. The mucin layer (innermost) — produced by goblet cells; enables tear film adhesion to the corneal epithelium

Dry eye disease occurs when this system fails in one of two primary ways:

Meibomian gland dysfunction (MGD) is the most common cause of dry eye — estimated to underlie 85–90% of cases. When Meibomian glands become obstructed, the lipid layer thins, evaporation accelerates, and tear osmolarity rises — triggering a cycle of ocular surface inflammation, cell damage, and further gland dysfunction. Omega-3 fatty acids address this directly by improving Meibomian gland lipid secretion quality and reducing the inflammatory cascade in the gland tissue.

Aqueous deficiency dry eye occurs when the lacrimal glands produce insufficient aqueous volume. This is less common, more associated with autoimmune conditions (Sjögren’s syndrome), and less responsive to nutritional intervention.

Nutritional contributing factors include:

• Omega-3 deficiency — the most directly relevant, affecting Meibomian gland lipid profile and systemic anti-inflammatory status
• Vitamin A deficiency — severe deficiency causes goblet cell loss and mucin layer compromise (less common in Western populations but relevant in restricted diets)
• Antioxidant insufficiency — allows oxidative stress on the ocular surface to amplify the inflammatory cycle

Lifestyle and environmental factors include:

• Prolonged screen use (reduced blink rate → tear film instability)
• Low-humidity environments (air conditioning, airplane cabins)
• Contact lens wear (disrupts lipid layer, increases evaporation)
• Aging — particularly in post-menopausal women, where androgen decline impairs Meibomian gland function significantly
• Certain medications (antihistamines, antidepressants, oral contraceptives)

This framework sets up the critical question for TheyaVue: which of these mechanisms does its formula actually address?

---

3. TheyaVue’s Ingredients: Which Ones Are Relevant to Dry Eye?

Let me walk through TheyaVue’s formula ingredient by ingredient and assess each one’s relevance to dry eye specifically. For a comprehensive review of the full ingredient panel and dosing, TheyaVue Ingredients and Side Effects provides the complete analysis.

Ingredient	Claimed Dose	Dry Eye Relevance	Evidence Level
Lutein	20 mg	Indirect (macular antioxidant; limited direct dry eye evidence)	Low for dry eye specifically
Zeaxanthin	4 mg	Indirect (same as Lutein)	Low for dry eye specifically
Bilberry Extract	120 mg	Indirect (vascular antioxidant; potential ocular surface circulation benefit)	Low for dry eye specifically
Vitamin C	500 mg	Moderate (aqueous humor antioxidant; supports lacrimal gland function)	Moderate
Vitamin E	400 IU	Moderate (membrane antioxidant; supports ocular surface cell integrity)	Moderate
Quercetin	50 mg	Higher (anti-inflammatory; inhibits inflammatory cytokines implicated in dry eye)	Moderate
N-Acetyl Cysteine (NAC)	600 mg	Higher (glutathione precursor; ocular surface oxidative stress reduction)	Moderate
Rutin	50 mg	Low for dry eye (bioflavonoid with vascular support; limited dry eye evidence)	Low
Zinc	8 mg	Low for dry eye specifically	Low

The three ingredients worth examining in detail for dry eye are Vitamin C, Quercetin, and NAC.

Vitamin C and Dry Eye

Vitamin C is present in the aqueous humor at concentrations approximately 25 times higher than in blood plasma — one of the highest tissue concentrations in the body. This suggests the eye has unusually high vitamin C requirements relative to other tissues, and that antioxidant protection of the aqueous environment is biologically prioritized.

The lacrimal gland, which produces the aqueous layer of the tear film, is an oxidatively active secretory tissue. Vitamin C supports lacrimal gland function through antioxidant protection of its secretory cells. A 2011 study in Experimental Eye Research found oxidative stress markers elevated in the tears of dry eye patients compared to controls — suggesting that antioxidant support at the ocular surface level is genuinely relevant to the disease process.

TheyaVue provides 500 mg of Vitamin C — well above the 90 mg RDA and within a range that meaningfully contributes to antioxidant tissue status.

Quercetin and Dry Eye Inflammation

Quercetin is increasingly recognized as a relevant ingredient in dry eye research, though most evidence remains at the mechanistic and preclinical level. Dry eye disease is now understood as fundamentally an inflammatory condition — chronic activation of inflammatory signaling (NF-κB pathway, IL-6, IL-1β, TNF-α) in the conjunctival and corneal epithelium drives the cycle of cell damage, goblet cell loss, and Meibomian gland dysfunction.

Quercetin inhibits NF-κB activation and reduces production of the proinflammatory cytokines implicated in this cycle. A 2021 study in Experimental Eye Research demonstrated that quercetin suppressed inflammatory mediators in corneal epithelial cells under oxidative stress conditions. This is mechanistically relevant to dry eye — particularly to the inflammatory perpetuation cycle that keeps dry eye chronic even after environmental triggers are addressed.

TheyaVue provides 50 mg of Quercetin — a modest dose by clinical trial standards (therapeutic trials typically use 500–1000 mg), but potentially meaningful as part of a broader antioxidant/anti-inflammatory matrix.

NAC and Ocular Surface Glutathione

N-Acetyl Cysteine is a glutathione precursor — it provides the rate-limiting substrate (cysteine) for endogenous glutathione synthesis in tissues throughout the body, including the corneal epithelium and lacrimal gland. Glutathione is the primary antioxidant defense system at the ocular surface.

In dry eye disease, oxidative stress depletes glutathione stores on the ocular surface, reducing the eye’s ability to protect itself from further oxidative damage. A 2016 study by Uchino et al. found significantly reduced glutathione levels in the tears and conjunctival cells of dry eye patients compared to controls — establishing glutathione depletion as a feature of the dry eye state rather than just a theoretical risk.

NAC has also been studied in topical formulations for dry eye (as a direct ocular surface antioxidant), though TheyaVue delivers it orally. The oral route supports systemic glutathione availability that benefits lacrimal gland and corneal epithelial cells, though the topical route has more direct evidence for tear film antioxidant effects.

TheyaVue provides 600 mg of NAC — a therapeutically meaningful dose consistent with the range used in antioxidant clinical trials. For the full context on what TheyaVue’s ingredients do, see the TheyaVue Review and TheyaVue Ingredients and Side Effects.

---

4. The Missing Ingredient: Why Omega-3s Matter for Dry Eye

This is the most important thing I need to tell you about TheyaVue and dry eyes: the formula does not contain omega-3 fatty acids, and omega-3s are the most evidence-based nutritional intervention specifically for dry eye disease.

Here is why they matter so much:

Omega-3s and Meibomian gland function. DHA and EPA are incorporated into the phospholipid bilayers of Meibomian gland cells. When omega-3 status is adequate, Meibomian glands produce more fluid, less viscous meibum (the oily secretion that forms the lipid layer of the tear film). When omega-3 status is low — as it is in most Western adults who do not regularly eat fatty fish — meibum becomes more waxy and prone to obstructing gland orifices, contributing to MGD.

Omega-3s and ocular surface inflammation. EPA is metabolized into eicosanoids with predominantly anti-inflammatory activity (prostaglandin E3, leukotriene B5). DHA is converted into resolvins and protectins — lipid mediators that actively resolve inflammation at the ocular surface. A 2013 study by Bhargava et al. in Contact Lens & Anterior Eye found omega-3 supplementation significantly improved tear film stability, Schirmer test values, and corneal staining scores in dry eye patients.

The DREAM trial context. In 2018, a large NIH-funded randomized controlled trial (the DREAM study, published in JAMA) found that omega-3 supplementation (3,000 mg/day EPA+DHA) was not significantly superior to olive oil placebo for dry eye symptoms. This trial generated controversy — its primary endpoint was symptom score, not objective tear film measures, and the olive oil control itself may have had active anti-inflammatory effects. Most dry eye researchers still recommend omega-3s based on the mechanistic evidence and the preponderance of positive smaller trials; the DREAM trial tempered but did not eliminate the omega-3 recommendation for dry eye.

The bottom line: if dry eye is your primary concern, you need omega-3 supplementation in the picture. TheyaVue does not provide it. This is not a criticism of TheyaVue’s formulation — the product was designed for macular health, not dry eye — but it is the most clinically important gap if you are evaluating TheyaVue specifically as a dry eye intervention.

For the full evidence review on dry eye nutritional interventions including omega-3s, Dry Eye Supplements Evidence covers every studied compound with trial citations.

---

5. What TheyaVue Can and Can’t Do for Dry Eyes

Let me be direct about this, because honest framing helps you make a better decision:

What TheyaVue can do for dry eye sufferers:

• Reduce oxidative stress at the ocular surface through Vitamin C, NAC, and Vitamin E — helping protect corneal epithelial cells from the oxidative damage that dry eye inflammation perpetuates
• Provide anti-inflammatory support through Quercetin that may reduce the inflammatory cytokine activity driving chronic dry eye disease
• Support lacrimal gland cell integrity through its antioxidant matrix, potentially supporting aqueous tear production health
• Provide macular and retinal antioxidant coverage through Lutein and Zeaxanthin — relevant if you have both dry eye and concerns about AMD or macular health, which often co-occur in older adults

What TheyaVue cannot do for dry eye sufferers:

• Replace the lipid layer function that omega-3-fed Meibomian glands provide — this is the primary driver of most dry eye and TheyaVue has no mechanism targeting it
• Provide anti-inflammatory lipid mediators (resolvins, protectins) — these come from DHA/EPA metabolism and are absent from TheyaVue’s formula
• Directly lubricate or hydrate the ocular surface — TheyaVue is an oral supplement, not an eye drop or mucin-support agent
• Address aqueous tear deficiency from autoimmune causes (Sjögren’s syndrome) — this typically requires prescription treatment

My clinical framing: TheyaVue is a useful antioxidant and anti-inflammatory support layer for dry eye sufferers, but it addresses a secondary mechanism (oxidative stress and inflammation) rather than the primary mechanism (Meibomian gland function and tear film lipid stability). Think of it as the anti-inflammatory backup to your omega-3’s lipid layer work — valuable as part of a complete strategy, not sufficient as the whole strategy.

Experience TheyaVue for Yourself — 60-Day Guarantee{rel=“nofollow sponsored”}

---

---

6. What Dry Eye Sufferers Report When Taking TheyaVue

Consumer feedback on TheyaVue from dry eye sufferers tends to fall into three categories — which map predictably onto the formula’s mechanism profile:

Positive reports typically describe:

• Reduced eye redness and irritation over 4–8 weeks of use
• Less eye fatigue during screen-heavy days
• Improved visual clarity in bright-light conditions
• Reduced sensitivity to light (photophobia), which can be a dry eye symptom
• Some users report reduced frequency of the gritty, burning sensation associated with dry eye — consistent with an anti-inflammatory effect on the ocular surface

Neutral or mixed reports typically describe:

• No change in tear volume or the sensation of dryness itself
• Relief of irritation but persistence of the need for lubricating eye drops
• Better results for screen-fatigue symptoms than for classic dry eye dryness

Negative reports typically describe:

• No dry eye benefit despite several weeks of use
• Expectation mismatch — users who expected a dry eye-specific supplement and did not find one

This pattern is consistent with what I would predict from the formula: anti-inflammatory and antioxidant benefits that reduce symptom severity in dry eye sufferers, without addressing the underlying tear film lipid instability that drives the core experience of dryness. Users who frame TheyaVue as an ocular anti-inflammatory support (rather than a dry eye cure) tend to have better outcome expectations matched to actual results.

It is worth noting that TheyaVue’s formula shares several key ingredients with the AREDS2 formulation — the evidence-based supplement for AMD prevention — through its Lutein/Zeaxanthin/Vitamin C/Vitamin E core. For users with both dry eye and macular concerns (a common pairing in adults over 55), TheyaVue offers a compelling dual-purpose rationale. See Macular Degeneration Supplements for the full evidence on AREDS2-aligned formulas.

---

7. Better Alternatives for Dry Eye (Omega-3 Focused)

Since TheyaVue lacks omega-3s — the most evidence-backed dry eye nutrient — what should dry eye sufferers consider instead, or alongside?

For Meibomian gland dysfunction and evaporative dry eye (most cases):

The primary evidence-based nutritional intervention is high-dose marine omega-3 supplementation:

• DHA + EPA combined dose: 2,000–3,000 mg/day of combined EPA + DHA (not just total fish oil milligrams)
• Triglyceride form vs. ethyl ester: Triglyceride-form omega-3s have approximately 70% better absorption than ethyl ester forms; re-esterified triglyceride forms have equivalent absorption
• Duration: A minimum 3-month trial for Meibomian gland function improvement; some research uses 6-month endpoints

For aqueous-deficient dry eye:

• Omega-3s remain useful as anti-inflammatory support
• Vitamin A (in severe deficiency cases) — through dietary sources (liver, orange/yellow produce) or supplementation
• Prescription options: cyclosporine eye drops (Restasis), lifitegrast (Xiidra) for moderate-to-severe aqueous deficiency

For dry eye with a strong inflammatory component:

• Quercetin and Vitamin C provide relevant support — both present in TheyaVue
• Curcumin / turmeric extracts have emerging evidence for ocular surface anti-inflammatory effects
• Astaxanthin (a carotenoid not in TheyaVue) has some early evidence for photostress and ocular fatigue reduction

Practical recommendation for someone who wants TheyaVue: Use TheyaVue for the antioxidant/anti-inflammatory layer it genuinely provides, and pair it with a separate high-quality omega-3 supplement providing at least 1,500–2,000 mg of combined EPA + DHA daily. This combination addresses dry eye’s primary mechanism (lipid layer / inflammation) and its secondary contributing factor (oxidative stress) simultaneously.

To understand how TheyaVue compares to iGenics, another comprehensive vision supplement in the market, TheyaVue vs. iGenics provides an ingredient-level comparison. For additional perspective on what makes a vision supplement evidence-based, Best Eye Vitamins: Evidence-Based Guide is the most comprehensive overview on the site.

---

8. Should Dry Eye Sufferers Take TheyaVue?

Here is my honest assessment as an RDN, broken down by who I think TheyaVue makes sense for within the dry eye patient population:

TheyaVue makes good sense for dry eye sufferers who:

• Want broad ocular antioxidant coverage alongside their omega-3 regimen — the Lutein/Zeaxanthin/Vitamin C/NAC/Quercetin combination addresses ocular surface oxidative and inflammatory mechanisms that omega-3s alone do not cover
• Have both dry eye symptoms AND concerns about macular health or AMD prevention — in this case, TheyaVue’s primary indication aligns well while also providing dry eye-relevant support
• Experience dry eye with significant screen-use component — Lutein and Zeaxanthin’s blue light filtering properties may reduce photostress and visual fatigue that exacerbates screen-related dry eye
• Are already managing dry eye with omega-3s and lubricating eye drops but want to add a comprehensive antioxidant layer
• Want a 60-day risk-free trial of a well-formulated ocular antioxidant without a long-term commitment

TheyaVue is less well-matched for dry eye sufferers who:

• Want a single supplement to address dry eye comprehensively — without adding omega-3s, TheyaVue will not address the primary driver of most dry eye
• Have severe or rapidly worsening dry eye symptoms — these cases warrant ophthalmological evaluation before relying on supplementation
• Have Sjögren’s syndrome or another autoimmune cause of dry eye — prescription therapies are the appropriate primary intervention
• Are looking specifically for tear volume support — no oral supplement reliably increases aqueous tear production in aqueous-deficient dry eye without addressing the underlying autoimmune mechanism

The 60-day money-back guarantee is the most relevant factor here. TheyaVue’s formulation is comprehensive from an ocular antioxidant standpoint, and the anti-inflammatory ingredients (Quercetin, NAC, Vitamin C) have genuine relevance to the inflammatory component of dry eye disease. If after 60 days you have experienced no improvement in ocular surface comfort, redness, or irritation, you have lost nothing. For the full picture on Is TheyaVue Legit and whether the company’s refund policy is reliable, that article covers the trust-building evidence.

---

9. Frequently Asked Questions

Does TheyaVue help with dry eyes?

TheyaVue was formulated primarily for macular health and AMD prevention, not specifically for dry eye disease. However, several of its ingredients — Vitamin C, Quercetin, and NAC — have mechanistic relevance to ocular surface health and the inflammation underlying dry eye. TheyaVue may provide supporting antioxidant and anti-inflammatory benefits that help dry eye sufferers, but it does not contain omega-3 fatty acids (DHA/EPA), which are the most evidence-based nutritional intervention specifically for dry eye disease.

What is the best supplement for dry eyes?

The most evidence-based nutritional intervention for dry eye disease is omega-3 fatty acids — specifically DHA and EPA from marine sources. For overall ocular surface antioxidant support, Vitamin C, Vitamin E, and NAC also have mechanistic relevance. TheyaVue provides antioxidant coverage but does not contain omega-3s, so for dry eye specifically, pairing TheyaVue with an omega-3 supplement would be a more complete approach. For a comprehensive evidence review on dry eye supplementation, see Dry Eye Supplements Evidence.

Does TheyaVue contain omega-3s?

No. TheyaVue does not contain omega-3 fatty acids (DHA or EPA). Its formula is built around fat-soluble antioxidants (Lutein, Zeaxanthin, Bilberry Extract), water-soluble antioxidants (Vitamin C, NAC), and flavonoids (Quercetin, Rutin). Omega-3s are the most evidence-backed nutritional intervention specifically for dry eye disease and Meibomian gland dysfunction. If dry eye is your primary concern, you should consider adding a high-quality fish oil or algae-based DHA/EPA supplement alongside TheyaVue.

Can TheyaVue help with digital eye strain?

Possibly. TheyaVue contains Lutein and Zeaxanthin, which concentrate in the macula and lens and filter high-energy blue light from screens. There is reasonable evidence that these carotenoids may reduce photostress and visual fatigue associated with prolonged screen use. Digital eye strain also has a dry eye component (reduced blink rate during screen use), for which TheyaVue’s antioxidant and anti-inflammatory ingredients may provide indirect support. For screen-heavy users, TheyaVue’s formula is more directly relevant than for classic aqueous-deficient dry eye. See Lutein and Zeaxanthin for Vision for the full research on these carotenoids.

Is TheyaVue good for sensitive eyes?

TheyaVue is an oral supplement, not a topical eye drop, so it does not come into direct contact with the ocular surface. Its ingredients are generally well-tolerated at the doses provided. Individuals with plant allergies (particularly to Bilberry or Quercetin sources) should review the ingredient panel carefully. People on blood thinners should consult their prescriber before taking Quercetin or Bilberry, as both have mild antiplatelet properties. For a full safety review, see TheyaVue Ingredients and Side Effects.

What vision issues is TheyaVue best for?

TheyaVue is best suited for macular health support and AMD prevention — conditions associated with oxidative damage to the retinal pigment epithelium and photoreceptor cells. Its Lutein and Zeaxanthin content targets the macula directly. It also has reasonable rationale for age-related lens clarity concerns (Vitamin C, NAC), night vision support (Bilberry), and general antioxidant protection against light-induced retinal oxidative stress. Dry eye disease is a secondary consideration — the formula provides relevant antioxidant and anti-inflammatory support but lacks omega-3s. For the comprehensive evaluation of TheyaVue across all use cases, Does TheyaVue Really Work provides the full analysis.

Check Current TheyaVue Pricing on the Official Website{rel=“nofollow sponsored”}

---

---

10. My Recommendation for Dry Eye + Vision Health

After reviewing TheyaVue’s ingredient panel against the dry eye literature, here is my professional recommendation as an RDN.

For dry eye sufferers who want a complete nutritional approach:

Step 1: Address the primary mechanism — Meibomian gland function and tear film lipid stability — with omega-3 supplementation providing at least 1,500–2,000 mg of combined DHA + EPA daily from a high-quality triglyceride-form fish oil or algae-based omega-3. This is the non-negotiable foundation for MGD-driven dry eye.

Step 2: Add comprehensive ocular antioxidant and anti-inflammatory coverage with a formula like TheyaVue, which provides Vitamin C, NAC, and Quercetin for ocular surface inflammatory and oxidative mechanisms, plus Lutein/Zeaxanthin for macular protection.

Step 3: Continue lubricating eye drops as needed during active dry eye periods — these provide immediate symptom relief that no oral supplement can replicate.

This three-layer approach is consistent with evidence-based dry eye management principles and gives you coverage at every level of the mechanism: lipid layer (omega-3s), ocular surface inflammation (Quercetin, NAC, Vitamin C from TheyaVue), and retinal protection (Lutein/Zeaxanthin from TheyaVue).

For dry eye sufferers who want a single supplement without the complexity:

TheyaVue’s 60-day guarantee makes it a low-risk trial option. Start there, assess your response at 60 days, and decide whether to add omega-3s based on your dry eye severity and response. If your dry eye is mild-to-moderate and has a significant screen-fatigue component, TheyaVue alone may provide meaningful relief. If your primary complaint is the sensation of dryness rather than irritation/inflammation, the omega-3 foundation is more important and TheyaVue should be the addition rather than the starting point.

For the full TheyaVue picture including my 90-day testing methodology, TheyaVue Review is the definitive starting point. TheyaVue Pricing and Discount Codes covers the current pricing tiers and any available discount options. You can also learn more about who we are and how we review supplements if you want context on how I evaluate products like this.

The 60-day money-back guarantee means the risk of finding out whether TheyaVue’s antioxidant and anti-inflammatory profile helps your dry eyes is effectively zero. That is the appropriate framing for any supplement trial: a structured experiment with a defined exit point, not a long-term commitment.

---

---

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.